Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-09-053528
Filing Date
2009-10-19
Accepted
2009-10-19 16:35:38
Documents
1
Period of Report
2009-10-06

Document Format Files

Seq Description Document Type Size
1 v163149_ex.html 4  
1 v163149_ex.xml 4 3804
  Complete submission text file 0001144204-09-053528.txt   5520
Mailing Address 350 CORPORATE BLVD ROBBINSVILLE NJ 08691
Business Address 350 CORPORATE BLVD ROBBINSVILLE NJ 08691 6092089688
NEXMED INC (Issuer) CIK: 0001017491 (see all company filings)

EIN.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEXMED, INC. 350 CORPORATE BLVD ROBBINSVILLE NJ 08691
Business Address
Oppenheim Leonard A (Reporting) CIK: 0001307647 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22245 | Film No.: 091126203